Improving our understanding of the underlying mechanism behind endocrine resistance and to identify biomarkers for an individualized approach to cancer therapy.
Organotypic model for breast cancer therapy prediction. We have successfully established our unselected ex vivo 3D cell culture (WTC) model.
The human epidermal growth factor receptor 2 (HER2) is overexpressed or gene amplified in about 15 % of breast cancers and is associated with aggressive tumors
We use established image analysis softwares to improve biomarker assessment in routine pathology. We also develop in-house deep-learning based models for next generation image analysis together with the Rantalainen lab.
Copyright by Hartman Lab. All rights reserved.